Highlights
KLSE: AIRASIA (5099)       AIRASIA GROUP BHD MAIN : Consumer
Last Price Today's Change   Day's Range   Trading Volume
0.745   0.00 (0.00%)  0.74 - 0.75  5,075,300
Analyze this stock with MQ Trader system

Financials


Market Cap: 2,490 Million

Market Cap 2,490 Million
NOSH 3,342 Million

Latest Audited Result:  31-Dec-2019

Latest Audited Result: 31-Dec-2019
Announcement Date 29-Jul-2020
Next Audited Result: 31-Dec-2020
Est. Ann. Date: 29-Jul-2021
Est. Ann. Due Date: 29-Jun-2021

Latest Quarter:  30-Sep-2020 [#3]

Latest Quarter: 30-Sep-2020 [#3]
Announcement Date 24-Nov-2020
Next Quarter: 31-Dec-2020
Est. Ann. Date: 27-Feb-2021
Est. Ann. Due Date: 01-Mar-2021
QoQ | YoY   14.21%  |    -1,555.77%

Annual (Unaudited) ( EPS: -9.10, P/E: -8.20 )

Revenue | NP to SH 12,445,628  |  -303,722
RPS | P/RPS 372.40 Cent  |  0.20
EPS | P/E | EY -9.10 Cent  |  -8.20  |  -12.20%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 1.33  |  0.56
YoY   -115.34%
NP Margin | ROE -2.30%  |  -6.83%
F.Y. | Ann. Date 31-Dec-2019  |  27-Feb-2020

T4Q Result ( EPS: -90.75, P/E: -0.82 )

Revenue | NP to SH 6,232,868  |  -3,032,996
RPS | P/RPS 186.50 Cent  |  0.40
EPS | P/E | EY -90.75 Cent  |  -0.82  |  -121.82%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.35  |  2.13
QoQ | YoY   -35.85%  |    -812.49%
NP Margin | ROE -57.47%  |  -259.30%
F.Y. | Ann. Date 30-Sep-2020  |  24-Nov-2020

Annualized Result ( EPS: -106.00, P/E: -0.70 )

Revenue | NP to SH 3,826,428  |  -3,541,634
RPS | P/RPS 114.50 Cent  |  0.65
EPS | P/E | EY -106.00 Cent  |  -0.70  |  -142.25%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   1.44%  |    -3,390.87%
NP Margin | ROE -111.70%  |  -302.78%
F.Y. | Ann. Date 30-Sep-2020  |  24-Nov-2020


Show?  YoY % Horiz. %
Last 10 FY Result
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 3,826,428 6,232,868 12,445,628 10,603,755 9,709,721 6,846,085 6,297,658 5,415,744 5,111,822 4,946,091 4,495,141 3,992,722 13.46%
  YoY % -38.61% -49.92% 17.37% 9.21% 41.83% 8.71% 16.28% 5.95% 3.35% 10.03% 12.58% -
  Horiz. % 95.84% 156.11% 311.71% 265.58% 243.19% 171.46% 157.73% 135.64% 128.03% 123.88% 112.58% 100.00%
PBT -4,462,778 -3,571,460 -549,755 1,364,710 2,087,778 1,704,691 215,150 22,701 361,235 962,557 777,017 1,099,299 -
  YoY % -24.96% -549.65% -140.28% -34.63% 22.47% 692.33% 847.76% -93.72% -62.47% 23.88% -29.32% -
  Horiz. % -405.97% -324.89% -50.01% 124.14% 189.92% 155.07% 19.57% 2.07% 32.86% 87.56% 70.68% 100.00%
Tax 188,661 -10,846 263,792 346,695 -495,774 -86,133 326,130 60,135 889 -172,949 -221,693 -32,422 -
  YoY % 1,839.46% -104.11% -23.91% 169.93% -475.59% -126.41% 442.33% 6,664.34% 100.51% 21.99% -583.77% -
  Horiz. % -581.89% 33.45% -813.62% -1,069.32% 1,529.13% 265.66% -1,005.89% -185.48% -2.74% 533.43% 683.77% 100.00%
NP -4,274,117 -3,582,306 -285,963 1,711,405 1,592,004 1,618,558 541,280 82,836 362,124 789,608 555,324 1,066,877 -
  YoY % -19.31% -1,152.72% -116.71% 7.50% -1.64% 199.02% 553.44% -77.12% -54.14% 42.19% -47.95% -
  Horiz. % -400.62% -335.77% -26.80% 160.41% 149.22% 151.71% 50.73% 7.76% 33.94% 74.01% 52.05% 100.00%
NP to SH -3,541,634 -3,032,996 -303,722 1,979,972 1,639,649 1,621,659 541,194 82,836 362,124 789,608 555,324 1,066,877 -
  YoY % -16.77% -898.61% -115.34% 20.76% 1.11% 199.64% 553.33% -77.12% -54.14% 42.19% -47.95% -
  Horiz. % -331.96% -284.29% -28.47% 185.59% 153.69% 152.00% 50.73% 7.76% 33.94% 74.01% 52.05% 100.00%
Tax Rate - % - % - % -25.40 % 23.75 % 5.05 % -151.58 % -264.90 % -0.25 % 17.97 % 28.53 % 2.95 % -
  YoY % 0.00% 0.00% 0.00% -206.95% 370.30% 103.33% 42.78% -105,860.00% -101.39% -37.01% 867.12% -
  Horiz. % 0.00% 0.00% 0.00% -861.02% 805.08% 171.19% -5,138.30% -8,979.66% -8.47% 609.15% 967.12% 100.00%
Total Cost 8,100,545 9,815,174 12,731,591 8,892,350 8,117,717 5,227,527 5,756,378 5,332,908 4,749,698 4,156,483 3,939,817 2,925,845 17.74%
  YoY % -17.47% -22.91% 43.17% 9.54% 55.29% -9.19% 7.94% 12.28% 14.27% 5.50% 34.66% -
  Horiz. % 276.86% 335.46% 435.14% 303.92% 277.45% 178.67% 196.74% 182.27% 162.34% 142.06% 134.66% 100.00%
Net Worth 1,169,690 1,169,690 4,444,825 6,216,071 6,383,170 6,623,478 4,461,542 4,528,367 5,002,502 4,863,050 4,029,621 3,620,748 2.30%
  YoY % 0.00% -73.68% -28.49% -2.62% -3.63% 48.46% -1.48% -9.48% 2.87% 20.68% 11.29% -
  Horiz. % 32.31% 32.31% 122.76% 171.68% 176.29% 182.93% 123.22% 125.07% 138.16% 134.31% 111.29% 100.00%
Dividend
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Div - 0 - 401,036 - - - - - 500,199 138,952 - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 259.98% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 288.61% 0.00% 0.00% 0.00% 0.00% 0.00% 359.98% 100.00% -
Div Payout % - % - % - % 20.25 % - % - % - % - % - % 63.35 % 25.02 % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 153.20% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 80.94% 0.00% 0.00% 0.00% 0.00% 0.00% 253.20% 100.00% -
Equity
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Net Worth 1,169,690 1,169,690 4,444,825 6,216,071 6,383,170 6,623,478 4,461,542 4,528,367 5,002,502 4,863,050 4,029,621 3,620,748 2.30%
  YoY % 0.00% -73.68% -28.49% -2.62% -3.63% 48.46% -1.48% -9.48% 2.87% 20.68% 11.29% -
  Horiz. % 32.31% 32.31% 122.76% 171.68% 176.29% 182.93% 123.22% 125.07% 138.16% 134.31% 111.29% 100.00%
NOSH 3,341,974 3,341,974 3,341,974 3,341,974 3,341,974 2,782,974 2,788,463 2,761,200 2,779,167 2,778,886 2,779,049 2,763,930 2.13%
  YoY % 0.00% 0.00% 0.00% 0.00% 20.09% -0.20% 0.99% -0.65% 0.01% -0.01% 0.55% -
  Horiz. % 120.91% 120.91% 120.91% 120.91% 120.91% 100.69% 100.89% 99.90% 100.55% 100.54% 100.55% 100.00%
Ratio Analysis
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -111.70 % -57.47 % -2.30 % 16.14 % 16.40 % 23.64 % 8.59 % 1.53 % 7.08 % 15.96 % 12.35 % 26.72 % -
  YoY % -94.36% -2,398.70% -114.25% -1.59% -30.63% 175.20% 461.44% -78.39% -55.64% 29.23% -53.78% -
  Horiz. % -418.04% -215.08% -8.61% 60.40% 61.38% 88.47% 32.15% 5.73% 26.50% 59.73% 46.22% 100.00%
ROE -302.78 % -259.30 % -6.83 % 31.85 % 25.69 % 24.48 % 12.13 % 1.83 % 7.24 % 16.24 % 13.78 % 29.47 % -
  YoY % -16.77% -3,696.49% -121.44% 23.98% 4.94% 101.81% 562.84% -74.72% -55.42% 17.85% -53.24% -
  Horiz. % -1,027.42% -879.88% -23.18% 108.08% 87.17% 83.07% 41.16% 6.21% 24.57% 55.11% 46.76% 100.00%
Per Share
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 114.50 186.50 372.40 317.29 290.54 246.00 225.85 196.14 183.93 177.99 161.75 144.46 11.09%
  YoY % -38.61% -49.92% 17.37% 9.21% 18.11% 8.92% 15.15% 6.64% 3.34% 10.04% 11.97% -
  Horiz. % 79.26% 129.10% 257.79% 219.64% 201.12% 170.29% 156.34% 135.77% 127.32% 123.21% 111.97% 100.00%
EPS -106.00 -90.75 -9.10 59.20 49.10 58.30 19.40 3.00 13.00 28.40 20.00 38.60 -
  YoY % -16.80% -897.25% -115.37% 20.57% -15.78% 200.52% 546.67% -76.92% -54.23% 42.00% -48.19% -
  Horiz. % -274.61% -235.10% -23.58% 153.37% 127.20% 151.04% 50.26% 7.77% 33.68% 73.58% 51.81% 100.00%
DPS 0.00 0.00 0.00 12.00 0.00 0.00 0.00 0.00 0.00 18.00 5.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 260.00% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 240.00% 0.00% 0.00% 0.00% 0.00% 0.00% 360.00% 100.00% -
NAPS 0.3500 0.3500 1.3300 1.8600 1.9100 2.3800 1.6000 1.6400 1.8000 1.7500 1.4500 1.3100 0.17%
  YoY % 0.00% -73.68% -28.49% -2.62% -19.75% 48.75% -2.44% -8.89% 2.86% 20.69% 10.69% -
  Horiz. % 26.72% 26.72% 101.53% 141.98% 145.80% 181.68% 122.14% 125.19% 137.40% 133.59% 110.69% 100.00%
Adjusted Per Share Value based on latest NOSH - 3,341,974
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 114.50 186.50 372.40 317.29 290.54 204.85 188.44 162.05 152.96 148.00 134.51 119.47 13.46%
  YoY % -38.61% -49.92% 17.37% 9.21% 41.83% 8.71% 16.29% 5.94% 3.35% 10.03% 12.59% -
  Horiz. % 95.84% 156.11% 311.71% 265.58% 243.19% 171.47% 157.73% 135.64% 128.03% 123.88% 112.59% 100.00%
EPS -106.00 -90.75 -9.10 59.20 49.10 48.52 16.19 2.48 10.84 23.63 16.62 31.92 -
  YoY % -16.80% -897.25% -115.37% 20.57% 1.20% 199.69% 552.82% -77.12% -54.13% 42.18% -47.93% -
  Horiz. % -332.08% -284.30% -28.51% 185.46% 153.82% 152.01% 50.72% 7.77% 33.96% 74.03% 52.07% 100.00%
DPS 0.00 0.00 0.00 12.00 0.00 0.00 0.00 0.00 0.00 14.97 4.16 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 259.86% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 288.46% 0.00% 0.00% 0.00% 0.00% 0.00% 359.86% 100.00% -
NAPS 0.3500 0.3500 1.3300 1.8600 1.9100 1.9819 1.3350 1.3550 1.4969 1.4551 1.2058 1.0834 2.30%
  YoY % 0.00% -73.68% -28.49% -2.62% -3.63% 48.46% -1.48% -9.48% 2.87% 20.68% 11.30% -
  Horiz. % 32.31% 32.31% 122.76% 171.68% 176.30% 182.93% 123.22% 125.07% 138.17% 134.31% 111.30% 100.00%
Price Multiplier on Financial Quarter End Date
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date AQR T4Q 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 -
Price 0.6700 0.6700 1.7000 2.9700 3.3500 2.2900 1.2900 2.7200 2.2000 2.7400 3.7700 2.5300 -
P/RPS 0.59 0.36 0.46 0.94 1.15 0.93 0.57 1.39 1.20 1.54 2.33 1.75 -13.79%
  YoY % 63.89% -21.74% -51.06% -18.26% 23.66% 63.16% -58.99% 15.83% -22.08% -33.91% 33.14% -
  Horiz. % 33.71% 20.57% 26.29% 53.71% 65.71% 53.14% 32.57% 79.43% 68.57% 88.00% 133.14% 100.00%
P/EPS -0.63 -0.74 -18.71 5.01 6.83 3.93 6.65 90.67 16.88 9.64 18.87 6.55 -
  YoY % 14.86% 96.04% -473.45% -26.65% 73.79% -40.90% -92.67% 437.14% 75.10% -48.91% 188.09% -
  Horiz. % -9.62% -11.30% -285.65% 76.49% 104.27% 60.00% 101.53% 1,384.27% 257.71% 147.18% 288.09% 100.00%
EY -158.17 -135.45 -5.35 19.95 14.65 25.45 15.05 1.10 5.92 10.37 5.30 15.26 -
  YoY % -16.77% -2,431.78% -126.82% 36.18% -42.44% 69.10% 1,268.18% -81.42% -42.91% 95.66% -65.27% -
  Horiz. % -1,036.50% -887.61% -35.06% 130.73% 96.00% 166.78% 98.62% 7.21% 38.79% 67.96% 34.73% 100.00%
DY 0.00 0.00 0.00 4.04 0.00 0.00 0.00 0.00 0.00 6.57 1.33 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 393.98% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 303.76% 0.00% 0.00% 0.00% 0.00% 0.00% 493.98% 100.00% -
P/NAPS 1.91 1.91 1.28 1.60 1.75 0.96 0.81 1.66 1.22 1.57 2.60 1.93 -4.46%
  YoY % 0.00% 49.22% -20.00% -8.57% 82.29% 18.52% -51.20% 36.07% -22.29% -39.62% 34.72% -
  Horiz. % 98.96% 98.96% 66.32% 82.90% 90.67% 49.74% 41.97% 86.01% 63.21% 81.35% 134.72% 100.00%
Price Multiplier on Announcement Date
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date AQR T4Q 27/02/20 27/02/19 27/02/18 23/02/17 26/02/16 26/02/15 26/02/14 26/02/13 22/02/12 24/02/11 -
Price 0.7100 0.7100 1.1100 3.0400 4.4600 2.7600 1.3900 2.7000 2.3800 2.6400 3.6500 2.3500 -
P/RPS 0.62 0.38 0.30 0.96 1.54 1.12 0.62 1.38 1.29 1.48 2.26 1.63 -17.13%
  YoY % 63.16% 26.67% -68.75% -37.66% 37.50% 80.65% -55.07% 6.98% -12.84% -34.51% 38.65% -
  Horiz. % 38.04% 23.31% 18.40% 58.90% 94.48% 68.71% 38.04% 84.66% 79.14% 90.80% 138.65% 100.00%
P/EPS -0.67 -0.78 -12.21 5.13 9.09 4.74 7.16 90.00 18.27 9.29 18.27 6.09 -
  YoY % 14.10% 93.61% -338.01% -43.56% 91.77% -33.80% -92.04% 392.61% 96.66% -49.15% 200.00% -
  Horiz. % -11.00% -12.81% -200.49% 84.24% 149.26% 77.83% 117.57% 1,477.83% 300.00% 152.55% 300.00% 100.00%
EY -149.26 -127.82 -8.19 19.49 11.00 21.11 13.96 1.11 5.47 10.76 5.47 16.43 -
  YoY % -16.77% -1,460.68% -142.02% 77.18% -47.89% 51.22% 1,157.66% -79.71% -49.16% 96.71% -66.71% -
  Horiz. % -908.46% -777.97% -49.85% 118.62% 66.95% 128.48% 84.97% 6.76% 33.29% 65.49% 33.29% 100.00%
DY 0.00 0.00 0.00 3.95 0.00 0.00 0.00 0.00 0.00 6.82 1.37 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 397.81% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 288.32% 0.00% 0.00% 0.00% 0.00% 0.00% 497.81% 100.00% -
P/NAPS 2.03 2.03 0.83 1.63 2.34 1.16 0.87 1.65 1.32 1.51 2.52 1.79 -8.18%
  YoY % 0.00% 144.58% -49.08% -30.34% 101.72% 33.33% -47.27% 25.00% -12.58% -40.08% 40.78% -
  Horiz. % 113.41% 113.41% 46.37% 91.06% 130.73% 64.80% 48.60% 92.18% 73.74% 84.36% 140.78% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Trade this stock and win a FREE I3investor T-shirt after 5 trades. Find out more.
  Like Social Forum Comment
  114 people like this.
 
ruby92 relax steady punpipi. steady boy
19/01/2021 8:49 PM
DickyMe Hi TripleH,

It is struggling to reach it's hyped level above RM10.

I can only feel pity for people who call themselves as investors but has herd mentality.
19/01/2021 9:00 PM
sharewiz118 ini AA still can terbang kah ? maybe bulan march can la because obat sudah mari
19/01/2021 9:53 PM
DickyMe Walaubagaimanapun, pandemik tidak akan kekal.

Pembelian kecil-kecilan akan meningkatkan jumlah saham dalam pegangan.
Lambat laun AA tetap akan terbang, ketika itu and akan ...

KAYA..KAYA..KAYA...AKU...KAYA...KAYA..KAYA...AKU
KAYA..KAYA...AKU.
19/01/2021 9:58 PM
sharewiz118 Tony F sudah dapat sugar mommy kah, hutang banyak kuat ohhhh...
19/01/2021 9:59 PM
sharewiz118 Jual belakang unta pun tak boleh habis bayar hutang lor
19/01/2021 10:02 PM
DickyMe Bulan Feb, up lagi!
Kuota Jan sudah diisi.
19/01/2021 10:04 PM
sharewiz118 alright gua caya sama lu, tomorrow top up 1 more lot
19/01/2021 10:10 PM
Steady Punpipi How long Can AA lasts without bailout....only TF and Mahcai knows and for us to bleed out...last to know
19/01/2021 10:12 PM
sharewiz118 the facts is AA certainly in deep shit but share market are base on sentiment hence, when vaccine are release to the public certainly it'll bring hope to some of the counter like AA. It doesn't look good today but during month of march it could paint a different picture
19/01/2021 10:16 PM
DickyMe Business itself is based on sentiment or demand.
19/01/2021 10:59 PM
Expertise https://www.google.com/amp/s/amp.theguardian.com/business/2021/jan/19/holiday-bookings-surge-as-covid-vaccinations-increase-travel-hopes
19/01/2021 11:19 PM
Hoho22 Flight to Holland!
19/01/2021 11:26 PM
MoneyMakers UK vaccination progressing well..33K+ cases for Tuesday (Monday 37K, Sunday 38K) vs Jan high 60K cases
20/01/2021 12:11 AM
MoneyMakers US vaccination also accelerating - US daily new cases have also fallen from a peak of 283,204 on January 8 to 137,885 on Tuesday, January 19. The seven-day rolling average of 200,407 is the lowest figure since the new year.
20/01/2021 12:22 AM
ruby92 All country currently waiting the vaccine results from israel with 30% of their people has been vaccinate up to date. We will see the results by the end of feb when.
20/01/2021 2:58 AM
ruby92 Then we will be millionaires
20/01/2021 2:58 AM
ruby92 Hehehehehe
20/01/2021 2:58 AM
ruby92 Damn I can’t sleep at night after my wife left me T_T
20/01/2021 2:59 AM
newbie4444 Border not open why good for AA?
20/01/2021 3:58 AM
newbie4444 74 sen AA cheap? Why TF not buying?
20/01/2021 3:59 AM
Woodswater https://www.nst.com.my/news/nation/2021/01/658855/mco-20-extension-tighter-sop-be-considered

Good news!
20/01/2021 8:06 AM
freddiehero wah.. good news
20/01/2021 8:20 AM
MoneyMakers Israel alrdy vaccinate 70% people over 60..early/mid Feb should see better signs of immunity

Israel will eventually publish their vaccination/testing results..real world results - highly anticipated
20/01/2021 9:22 AM
kingpuk91 bought at 0.55. should hold or collect? Thanks in advance all Sifus here
20/01/2021 9:35 AM
DickyMe "Posted by ruby92 > Jan 20, 2021 2:58 AM | Report Abuse

All country currently waiting the vaccine results from israel with 30% of their people has been vaccinate up to date. We will see the results by the end of feb when."

========================================

The most important observation should be on any deaths caused by vaccine itself then concentrate on effectiveness of controlling or eradicating the virus.

If the results are appreciable then recovery from pandemic is on its way.
20/01/2021 9:38 AM
strattegist relax
20/01/2021 10:19 AM
TripleH You are right Dicky, the rm4 man! There's just no momentum for glove counter anymore no matter good news or good report! Better invest in the future!
20/01/2021 10:27 AM
sampooler https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/
20/01/2021 10:43 AM
Woodswater kingpuk91 bought at 0.55. should hold or collect? Thanks in advance all Sifus here
20/01/2021 9:35 AM

Covid-19 vaccine safe for those with chronic illness; women advised to defer conception for a month after jabs, says Singapore’s Health Ministry https://newswav.com/A2101_y4wPqO?s=A_36YmmU6

Singapore health Minister department also used as Asean guideline

I matched 745
Happy to rejoin AA
This time i hold long term
No gimmicks!
Wakakakaka
20/01/2021 11:03 AM
freifeit Relax relax relax...
20/01/2021 11:08 AM
strattegist relax and cool
20/01/2021 11:33 AM
perx135305 Relax
20/01/2021 12:22 PM
perx135305 Look long term. The biggest risk in holding AA now is the chance of RI.
20/01/2021 12:23 PM
freifeit Institutions are still collecting AA shares today..

Just relax..
20/01/2021 1:10 PM
MoneyMakers Gloves sure no hope alrdy, Supermx heading towards 5.0..even europe glove shares down - signal market optimistic on vaccination progress

Future is recovery/tech/banks
20/01/2021 1:22 PM
Woodswater https://www.theedgemarkets.com/article/fernandes-airasia-not-cancelling-airbus-orders-moment

Bad news!
20/01/2021 1:28 PM
USASTOCKSNUMBA1 DAMP IT
20/01/2021 1:28 PM
ruby92 https://www.bloomberg.com/news/articles/2021-01-19/covid-cases-fall-in-all-regions-even-as-u-s-faces-400-000-dead?utm_campaign=socialflow-organic&cmpid=socialflow-facebook-business&utm_medium=social&utm_source=facebook&utm_content=business&fbclid=IwAR2O2WEmhFQtVP_sXXHpY8qVva9Kr75qgJgY9CLlcp6dVcSbBiTEDIZXiQE
20/01/2021 1:37 PM
ruby92 Vaccines are working. Let’s see what’s going to happened by end of feb hehehehe
20/01/2021 1:38 PM
strattegist relax
20/01/2021 1:52 PM
ruby92 Relax brader brader relax. Mantap choii
20/01/2021 1:54 PM
Woodswater https://www.globaltimes.cn/page/202101/1213297.shtml

Good news
Wakakakaka
20/01/2021 2:34 PM
ykyew11 Norway's health regulator already came out to say that the deaths are not linked to the vaccine. Globaltimes is a chinese based news outlet, so obviously they have a vested interest to say that China's vaccines are safer or better than Pfizer.
20/01/2021 2:55 PM
strattegist relax
20/01/2021 3:16 PM
ruby92 https://www.google.com.my/amp/s/mobile.reuters.com/article/amp/idUSR4N2HZ01X
20/01/2021 3:44 PM
ruby92 Another promising vaccine from russia wohoo
20/01/2021 3:44 PM
strattegist cool
20/01/2021 4:35 PM
ruby92 we can go through this together hehe
20/01/2021 4:58 PM
strattegist relax and cool
20/01/2021 6:04 PM